Delporincis A Clinical Stagebiopharmaceutical Company Based In San Franciscocaliforniathecompany Focuses On Developing Onceyearly Therapies For Chronic Conditions Using Its Proprietary Drug Delivery Technologiesdelpor Specializes In Sustained Releaseformulations Delivered Through A Non Mechanical Subcutaneous Implant Deviceenhancing Patient Adherenceand Therapeutic Outcomes Thecompany S Prozora C Technology Allows For Zero Order Releasepharmacokineticsensuring Consistent Drug Levels Over Timetheprozora C Implant Is A Small Devicethat Can Beplaced Under Theskin In A Quickin Officeproceduredelpor S Pipelinetargets Various Chronic Conditionsincluding Psychiatric Disorders Likeschizophrenia And Bipolar Disordermetabolic Conditions Such As Growth Hormonedeficiencyand Infectious Diseases Likehepatitis Cthecompany Collaborates With Pharmaceutical Partners To Repurposeapproved Drugs Into Long Acting Formulationsaiming To Improvetreatment Regimens For Patients And Healthcareproviders
